2 terminated, 1 not yet recruiting, 1 unknown. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 2, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Severe Preeclampsia: new trials by email Literature Review of Severe Preeclampsia trials Research Report on Severe Preeclampsia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Furosemide vs Placebo in Severe Preeclampsia Postpartum Furosemide, Folic Acid 5 MG - Severe Preeclampsia | Phase 2 | Not yet recruiting | Universidad Nacional Autonoma de Honduras | 186 | 2026-06-15 | 2026-06-15 |
| Protocols for Magnesium Sulfate Maintenance Dose in Overweight and Obese Women Diagnosed With Preeclampsia maintenance magnesium sulphate1g/h, maintenance magnesium sulphate2g/h - Severe Preeclampsia | Phase 1 / Phase 2 | Unknown | Ain Shams University | 100 | 2024-07-01 | 2024-07-03 |
| Complement Regulation to Undo Systemic Harm in Preeclampsia Eculizumab - Preeclampsia, Severe Preeclampsia | Phase 2 | Terminated | Cedars-Sinai Medical Center | 2 | 2021-09-13 | 2023-11-29 |
| Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia AMAG-423 (digoxin immune fab), Placebo - Severe Preeclampsia | Phase 2 / Phase 3 | Terminated | AMAG Pharmaceuticals, Inc. | 58 | 2017-04-12 | 2026-05-22 |
Pre-Eclampsia (4) · HELLP Syndrome (1) · Hypertension (1)
Female Urogenital Diseases and Pregnancy Complications (4) · Hypertension, Pregnancy-Induced (4) · Pregnancy Complications (4) · Urogenital Diseases (4) · Cardiovascular Diseases (1) · Vascular Diseases (1)
Folic Acid (1) · Furosemide (1) · digoxin antibodies Fab fragments (1) · eculizumab (1)
AMAG Pharmaceuticals, Inc. (1) · Ain Shams University (1) · Cedars-Sinai Medical Center (1) · Universidad Nacional Autonoma de Honduras (1)
United States (2) · Honduras (1) · Poland (1) · South Africa (1)